2-Bromo-1-(4-cyclohexylphenyl)ethanone, 95%, 500mg

1-(4-Nitro-3-trifluoromethylphenyl)-piperazine, 98.0%, 2g

GC capillary column ROTI®Cap-1701, 50 m, 0.20 mm, 0.20 µm, 1 Piece(s)

(Z)-2-Oxopropanal oxime, 95.0%, 1g

5-Bromo-2-fluoro-4-methylbenzenesulfonamide, 97%, 1g

2-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 95.0%, 250mg

N-Ethyl-N-isopropylpropan-2-amine trihydrofluoride, 95.0%, 1g

1-(m-Tolyl)imidazoline-2-thione, 1g

N-Methylhydroxylamine hydrochloride, 95.0%, 10g

Ethyl 2-phenoxyacetoacetate, 95.0%, 1g

N-(3-methylpyridin-2-yl)ethane-1,2-diamine, 95.0%, 250mg

Methyl 2-(5-amino-2-fluorophenyl)acetate, 95%, 1g

(S)-2-((4-((3-Fluorobenzyl)oxy)benzyl)amino)propanamide, 95.0%, 1g